Regarding prognostic markers, ARID1A, MLL, [14] LRP1B, and TP53 mutations, particularly the hotspot mutations R249S and V157F, are associated with poor prognosis for patients with HCC [15, 16]. Here, TP53 is linked to hepatocellular carcinoma.